Document is current
Any future updates will be listed below
-
Authors
Klingberg, Eva http://orcid.org/0000-0001-6858-6413
Bilberg, Annelie
Björkman, Sofia
Hedberg, Martin
Jacobsson, Lennart
Forsblad-d’Elia, Helena
Carlsten, Hans
Eliasson, Björn
Larsson, Ingrid
-
Funding
Funding for this research was provided by:
The Health and Medical Care Executive Board of the Västra Götaland (VGFOUREG-565931)
Rune och Ulla Amlövs Stiftelse för Neurologisk och Reumatologisk Forskning (2016-097)
Inger Bendix foundation for medical research (.)
The Swedish Rheumatology Association research grant in collaboration with Roche (.)
Stiftelsen Psoriasisfonden (.)
The Swedish state under the agreement between the Swedish Government and the county councils, the ALF-agreement (ALFGBG-825511)
Gothenburg Society of Medicine (GLS-788661)
- License Information
-
More Information
Article History
Received: 16 September 2018
Accepted: 2 January 2019
First Online: 11 January 2019
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee in Gothenburg and carried out in accordance with the Helsinki declaration. All participants gave their written informed consent.
: Not applicable
: The authors declare that they have no financial or nonfinancial competing interests. The patients were able to buy the VLED at a reduced price from Cambridge Weight Plan Limited, Solna, Sweden.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
